openPR Logo
Press release

Gaucher Disease Treatment Market, by Disease Type, Therapy Type

06-22-2018 03:31 PM CET | Health & Medicine

Press release from: Pharma & Healthcare Industry

Gaucher Disease Treatment Market, by Disease Type, Therapy Type

Gaucher disease is an autosomal recessive inherited metabolism disorder where a type of fat (lipid) called glucocerebroside is unable to degrade. Body synthesis enzyme called glucocerebrosidase, which breakdowns and reprocesses glucocerebroside. Gaucher disease is caused by mutations of a single gene called GBA, which leads to very low levels of glucocerebrosidase enzyme leading to low degradation of glucocerebroside. There are three types of Gaucher disease namely: type 1, type 2, and type 3. Type 1 is the most common type of Gaucher disease while Type 2 and 3 are not as common as type 1.

Click To Continue Reading :
https://www.coherentmarketinsights.com/ongoing-insight/gaucher-disease-treatment-market-1225

Approval of novel drugs is expected to boost growth of Gaucher disease treatment market

U.S. Food and Drug Administration (FDA) has approved multiple drugs in last few years for the treatment of disease. In 2010, FDA approved Vpriv (velaglucerase alfa), an enzyme replacement therapy (ERT), for type 1 Gaucher disease. In 2012, Elelyso (taliglucerase alfa) and in 2014, Cerdelga (eliglustat) was approved by FDA for type 1 Gaucher disease. These drugs offer variety of options based on their requirements, in turn is expected to boost the growth of the market.

Get The Holistic SAMPLE With Research Methodology:
https://www.coherentmarketinsights.com/insight/request-sample/1225

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Visit our news Website: https://www.coherenttimes.org

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gaucher Disease Treatment Market, by Disease Type, Therapy Type here

News-ID: 1094685 • Views: 607

More Releases from Pharma & Healthcare Industry

Thalidomide Market - Global Industry Insights, Trends, Outlook, and Opportunity …
Worldwide Market Reports added Latest Research Report titled "Thalidomide Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026" to its Large Report database. Thalidomide is an immunomodulatory drug and a prototype of the thalidomide class of drugs. It is mainly used in the treatment of certain cancers (multiple myeloma) and of a complication of leprosy. It is sold under the brand name Immunoprin. It has many applications in the
Interventional Oncology Solutions Market Ablation Radiofrequency Ablation, Cryo …
Interventional oncology is a field of medical science, which includes treatment and diagnosis of cancer and other problems related to cancer using minimally invasive procedures. Interventional oncology uses various techniques such as Ultrasound, computed tomography, X-ray, and magnetic resonance imaging (MRI) to treat tumors located in various organs of the body. Interventional oncology procedures are usually used to treat metastatic or primary cancer. These procedures can be used to treat
Rx Medical Food Trends Estimates High Demand by 2024
Medical food is a category of products for dietary management or supportive therapy for specific disease or medical conditions such as pulmonary and metabolic disorders. Ingredients used in medical foods must have generally recognized as safe (GRAS) status, which is assigned to naturally found food materials. Medical food is different from nutritional food, dietary supplements, and prescription drugs. Medical food is protein-based, nutrient-based (Omega 3 fatty acids, chelated zinc, and
Specialty CRO's Market - Regional Insights
On the basis of geography, global specialty CROs market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to dominate the market over the forecast period, owing to the fact that pharmaceutical and biotech companies in this region spends significant amount on research and development, in order to bring novel therapies to the market. Click To Continue Reading; https://www.coherentmarketinsights.com/ongoing-insight/specialty-cros-market-1627 As per the estimation

All 5 Releases